Arrowhead Pharmaceuticals GAAP EPS of $0.45 beats by $1.06, revenue of $146.26M beats by $100.78M

• Arrowhead Pharmaceuticals press release (NASDAQ:ARWR): Q2 GAAP EPS of $0.45 beats by $1.06.
• Revenue of $146.26M (-3.6% Y/Y) beats by $100.78M.